SCWORX CORP (WORX)
OTCHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-09
$4.51-14.10%
Close 2026-09-08 · 1-day change
OTCHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-09
Warn: Primary pillar under pressure — maintain Nasdaq listing compliance: MVPHS < $1M vs $1M target.
SCWORX is a loss-making company facing severe challenges. It recently faced Nasdaq delisting notices due to low stock price. The company has taken steps like warrant inducement agreements to stabilize. If it can improve its financial health, it may recover from its deep drawdown.
SCWORX is deeply unprofitable and has lost over 80% from its high. Nasdaq delisting risks remain. Analysts expect flat or slightly negative revenue growth. The company may fail to regain investor confidence or profitability.
The market expects about 0% revenue growth and justifies the current low valuation. Our fair value is $6.56, reflecting the company's high risk and poor financial standing. We see no upside priced in given the deep drawdown and ongoing challenges.
Breaks if: failure to meet Nasdaq listing price requirements
Breaks if: operating losses widen or no improvement next year
YoY revenue growth falls below -1% next year
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
WORX represents a speculative growth investment with a focus on the healthcare sector. The current thesis state remains intact, despite recent regulatory challenges and ongoing losses.
The market appears to have priced in a low level of fragility, indicating that the current valuation is justified compared to peers. There is a notable expectations gap, suggesting that investors may not fully anticipate the potential risks ahead.
Fundamentals are likely to remain under pressure due to ongoing losses and regulatory compliance issues. However, there has been some operational improvement, as indicated by a reduction in operating losses over recent quarters.
The long-term thesis hinges on the performance of sector bellwethers and the ability of WORX to maintain its Nasdaq listing. Economic indicators, such as the jobs report, will also play a crucial role in shaping the outlook.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
In the next 1 to 3 years, WORX's performance will depend on external market conditions and internal management execution. Not investment advice.